- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Type 2 diabetes: Low energy diet with formula meal replacements best for weight loss, remission
Very low energy diets and formula meal replacements are most effective for weight loss, diabetes remission.
Scotland: A recent study in the journal Diabetologia has suggested that very low energy diets and formula meal replacement appear to be the most effective approaches for weight management and remission in people with type 2 diabetes (T2D). The macronutrient content was not found to be important to outcomes. Further, programs including a hypocaloric formula 'total diet replacement' induction phase were most effective for type 2 diabetes remission.
The researchers add that there is a need for well-conducted research to assess longer-term impacts on weight, blood sugar control, clinical outcomes, and diabetes complications as most of the evidence are restricted to 1 year or less.
The research was conducted by Professor Mike Lean, Dr. Chaitong Churuangsuk, and colleagues at the Universities of Glasgow and others from Cambridge (UK) and Otago (New Zealand) Universities. The group analyzed published meta-analyses of which type of diet is best for achieving and then maintaining weight loss in adults with T2D.
While T2D is influenced by both genetic and environmental factors, it is rising levels of overweight and obesity which have driven the current global epidemic of diabetes. The authors note: "Without strategic commitment internationally on effective prevention strategies, type 2 diabetes will affect an estimated 629 million people worldwide by 2045."
The onset of T2D is primarily driven by weight gain to the point that it becomes unhealthy. The amount of weight gain needed varies widely between individuals. The development of the disease involves a complex interaction of gut hormones, low-grade inflammation, and possibly metabolites from the gut microbiota. It develops in susceptible individuals and families who tend to have large waists and who accumulate fat in their liver, pancreas, and muscles. This impairs organ functions, resulting in hyperglycemia (abnormally high blood sugar), commonly associated with hypertension (high blood pressure) and abnormal blood fats.
T2D requires lifelong management, but even with treatment, it can cause disabling, painful, and life-shortening complications. However, sufficient weight loss can remove the abnormal body fat from the liver and pancreas and reverse diabetes.
Weight loss is critical to the management and remission of T2D and has been shown to improve all the related cardiometabolic risk factors and reduce the patient's need for medication.
In the UK DiRECT study, funded by Diabetes UK, almost 80% of people with T2D for up to 6 years who lost over 10kg, and maintained the weight loss of over 10 kg, remained in remission from diabetes for at least 2 years.
While there is widespread awareness of the benefits of weight loss for people withT2D, there is a lack of authoritative guidance over dietary advice, to inform both patients and healthcare providers. Ill-informed controversy over diet types has contributed to inaction and delays in providing effective treatment. Current guidelines stress the importance of personalized weight management and state that various diet strategies may be effective but do not provide information about diet composition. This can lead to patients following diets based on distorted evidence and misleading claims.
Adherence to any energy-reduced diet will lead to sustained weight loss, provided that energy (calorie) use exceeds intake. However, in practice, adherence rates and weight losses vary widely, even within the same diet program, and some comparisons between diets appear to show conflicting results.
The researchers wanted to help resolve these uncertainties and to inform clinical decision making and guideline development, as part of a program of work to update the recommendations of the European Association for the Study of Diabetes (EASD).
For this new study, the researchers collected and systematically reviewed all the relevant world publications of diet trial meta-analyses for weight management of people with T2D and all studies which have reported remissions of T2D.
Their analysis found that the greatest weight loss was achieved with very low energy formula diets, used as 'Total Diet Replacement' at 1.7-2.1 MJ/day [400-500 kcal/day] for 8-12 weeks, which led to an average 6.6kg more weight lost compared to food-based low-energy diets (4.2-6.3 MJ/day [1000-1500 kcal/day]). Formula meal replacements were also found to be superior to food-based low-energy diets alone, achieving 2.4kg greater weight loss over 12-52 weeks.
The published evidence showed that low-carbohydrate diets were no better than higher carbohydrate (low-fat) diets for weight loss.
For remission of T2D, there are no direct comparisons between diet types, but published studies showed the best remission rates of 46-61% at 12 months with programs that include a formula 'Total Diet Replacement' of 830 kcal/day for 12 weeks, followed by a relatively low-fat high carbohydrate diet and meal replacements for long-term maintenance. With low carbohydrate diets, reported remission rates are much lower at 4%-19% of those who tried the diet.
They add: "The Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3-2 kg) or no difference from conventional relatively low fat/high carb control diets…The evidence, albeit of variable quality, is rather consistent showing that no one diet type is superior over others for weight management in type 2 diabetes."
The researchers conclude: "Published meta-analyses of diets for weight management in people with type 2 diabetes do not support recommending any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets."
A limitation of the trials examined by this study is that the benefits from weight management depend largely on long-term control of body weight, while most of the currently available evidence relates only to short-term outcomes. Successful long-term maintenance of weight may require different behavioral strategies to those effective for the weight-loss phase. Few trials have reported data beyond 12 months. The team suggests: "Well-conducted research is needed to assess longer-term impacts on weight, blood sugar control, clinical outcomes, and diabetes complications."
Reference:
The study titled, "Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission," is published in the journal Diabetologia.
DOI: https://diabetologia-journal.org/wp-content/uploads/2021/11/Churuangsuk.pdf
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751